Patent Awarded to Unigen Pharmaceuticals for Novel Policosanol Ingredient That Maintains Healthy Blood Lipid Levels

Lacey, WA – January 19, 2005 – Unigen Pharmaceuticals, Inc., a leading research and development facility and supplier of proprietary, biologically active plant-derived ingredients to the natural products and pharmaceutical industries, has announced that the U.S. Patent and Trademark Office recently issued the company a utility patent for using its proprietary policosanol ingredient to aid the body in maintaining healthy blood lipid levels.
This novel ingredient is derived from a wax from China, utilized for centuries by local communities as a nutrition source due to its high protein and amino acid profile. Unigen’s policosanol ingredient will be further developed into commercial products targeting health concerns associated with aiding the body in blood lipid management.
Recent guidelines published by the American Heart Association recommend that cholesterol-lowering drugs be used more aggressively in people at risk of cardiovascular disease. Unfortunately, these drugs can result in liver damage or other side effects.

This natural policosanol ingredient was developed by Unigen’s Chief Scientific Officer Dr. Qi Jia and Natural Product Chemist Dr. Jifu Zhao. Dr. Jia indicated that in the past, a low harvest yield from natural sources, coupled with the high cost for isolation and purification, have limited policosanol usage. “We developed this novel policosanol product from a sustainable natural source to address various health concerns, such as those related to unhealthy cholesterol levels, in a way that is natural and effective. Unigen will continue to develop products that provide consumers with all-natural, alternative choices for improved health and wellness.”

# # #

About Unigen Pharmaceuticals, Inc.

Unigen Pharmaceuticals, Inc. ( is a leading natural products research and development company and proprietary ingredients supplier. The company is dedicated to the discovery of botanically derived therapeutic compounds that address consumer health needs and help improve the quality of human life. Its research and discovery process includes extensive work at both the human cell and gene level. Unigen and sister company Aloecorp each focus on identifying and studying the unique ingredients of medicinal botanicals (Aloecorp’s focus is on Aloe vera) and then formulating proprietary raw materials for use in cosmeceutical, nutraceutical and pharmaceutical products.

Regan Miles, Executive Vice President
Unigen Pharmaceuticals, Inc.
[email protected]

Hide comments


  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.